Johnson & Johnson reported that Spravato treated over 100,000 patients in 77 countries worldwide, including roughly 80,000 in ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression. Here's what ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... Approval ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for depression, a new analysis suggests. The hallucinogenic drug — a controlled ...

It was a pleasure getting to know the true Indira Gandhi through the lens of Kangana Ranaut. She effortlessly fitted into the role with her facial expressions and nasal twang. Emergency highlights the ...

LONDON - UK patients are “coming to harm” with hospitals so overwhelmed people are dying in corridors awaiting treatment amid a “collapse in care standards”, a report said on Jan 16.

Because public health agencies have learned that these patients had bird flu days or weeks after the person became ill, it has hampered efforts to find out how they were exposed and make sure they ...